Our investigation demonstrates the potential of IIM in improving myocardial cell apoptosis, inflammation, and autophagy triggered by myocardial infarction through the inhibition of the KLF4/NF-κB pathway in both intracellular and extracellular environments. The gene discussed is NFKB1; the disease is myocardial infarction.